<DOC>
	<DOCNO>NCT01035580</DOCNO>
	<brief_summary>The main objective study determine maximum tolerable dose safety intravaginal curcumin normal population woman ( woman evidence cervical cytological abnormality pap test ) .</brief_summary>
	<brief_title>Trial Safety Pharmacokinetics Intravaginal Curcumin</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Between age 1845 year age enrollment Currently use reliable birth control method ( oral contraceptive pill , DepoProvera permanent sterilization ) Able provide write informed consent Provide male partner notification letter Have Pap test negative pap ( cervical intraepithelial lesion ) within 45 day prior screen Have regular monthly menses ( every 2135 day ) amenorrhea due hormonal contraceptive use Agree undergo pelvic exam colposcopy per protocol Able willing complete Study Diary Agree wear condom act vaginal intercourse abstain vaginal intercourse 14 day Agree abstain sexual intercourse 48 hour prior enrollment visit Agree insert curcumin gelatin capsule require per protocol Agree abstain nonsteroidal antiinflammatory drug ( NSAIDS ) 14 day Agree abstain product contain curcumin food consumption curcumin 14 day Agree abstain follow activity least 48 hour prior enrollment Day 14 visit : insertion object vagina except penis , receive oral anal sex , use diaphragm , cervical cap , female condom , vaginal contraceptive ring , use vaginal product study gelatin capsule , include douche , lubricant , spermicide feminine hygiene product , participate vaginal cream contraceptive study Agree test HIV status via enzyme immunoassay ( EIA ) /Western Blot Are postmenopausal Have hysterectomy removal cervix Have clinically significant chronic medical condition consider progressive , include : coronary disease , congestive heart failure , chronic obstructive lung disease , diabetes mellitus , chronic renal disease , active peptic ulcer disease , chronic hepatic disease , multiple sclerosis , seizure disorder require medication , coagulation platelet disorder . Chronic nonprogressive intermittent syndrome exclude , include migraine headache , mild reactive airway disease , control hypertension , stable pain syndrome , benign gastric reflux . Have intrauterine device ( IUD ) form birth control Have history malignancy current ( within 45 day screen ) pap cervical intraepithelial lesion . Currently document laceration visual inspection present cervix , vagina , vulva perineum . Are pregnant plan become pregnant next three month Are currently breastfeed Have history sensitivity allergy compound use study Have Grade 2 high renal hematologic abnormality , define Table Grading Severity Adult Adverse Events screen positive bacterial urine culture . Women positive bacterial urine culture screening allow enroll appropriate treatment repeat evaluation normal . In three month prior enrollment following : Treatment Cervical disease gynecologic surgery , A pregnancy abortion , An IUD , Breakthrough menstrual bleeding vaginal bleeding follow vaginal intercourse Signs , see pelvic exam screening , consistent STD include vaginitis , cervicitis genital ulcer Signs , see pelvic exam , genital trauma Signs genital tract infection laboratory evaluation . Women Candida vaginitis bacterial vaginosis screening allow enroll appropriate treatment repeat evaluation normal . In three month prior enrollment following : History treatment diagnosis new STD , Genital herpes simplex virus infection outbreak , Exchanged sex money , drug gift Are currently use , last year use intravenous drug ( except therapeutic use ) , cocaine recreational drug , abuse alcohol define alcohol use require hospital admission detoxification therapy . Have condition opinion investigator might interfere evaluation study objective . HIV positive</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>chemoprevention</keyword>
	<keyword>curcumin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
</DOC>